Disc Medicine, Inc. — Director's Dealing 2021

May 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-04-29

Reporting Person: GEMAYEL GEORGES (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-29	Stock Option (Right to Buy)	$11.92	A	45466	Acquired	2031-04-28	Common Stock (45466)	Direct

Footnotes

F1: This option shall vest and become exercisable over a period of three years from the Vesting Start Date, April 29, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting in eight quarterly installments thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.